Somerville Development Partners

Executive Summary

Somerville Development Partners is a boutique European regulatory affairs consultancy established in 2017, headquartered in London, UK. The firm delivers strategic and operational regulatory support to innovative pharmaceutical, biopharmaceutical, and biotechnology companies, with a particular focus on navigating the complex EU and US regulatory pathways from early-stage planning through market authorization. By leveraging its registered SME status with the European Medicines Agency (EMA), Somerville secures financial and regulatory benefits for its clients, positioning itself as a dedicated partner for small and medium-sized enterprises (SMEs) in the life sciences sector. The company’s deep expertise in regulatory strategy, dossier preparation, and agency interactions enables clients to accelerate development timelines, reduce risks, and achieve successful product approvals in both Europe and the United States.

Upcoming Catalysts (preview)

• Q3 2026EMA SME Status Renewal Confirmation90% success
• Q4 2026Major Client Regulatory Submission Win (e.g., MAA or NDA)50% success
• Q2 2026Expansion of US Regulatory Advisory Services70% success